Carlsmed Inc. (CARL) shares climbed Wednesday after the company announced a significant product milestone: the first personalized cervical plating procedure using its corra Cervical Plating System. While broader markets went nowhere in particular, this development gave investors something concrete to get excited about.
Carlsmed Hits Milestone With First Custom Cervical Plating Procedure
Get Market Alerts
Weekly insights + SMS alerts
Breaking Ground at UCSF
The procedure took place at the University of California, San Francisco, representing a meaningful step forward for the medical device company. Carlsmed plans to conduct additional evaluations over the coming months before aiming for a full commercial launch later this year.
So what makes this system different? The corra platform is designed to stabilize the cervical spine during fusion procedures, but with a twist: it uses patient-specific plates tailored to individual anatomical needs. The idea is to enhance surgical precision and improve patient outcomes by moving away from one-size-fits-all hardware.
The technology leverages Carlsmed's digital surgery ecosystem to customize key anatomical aspects before the patient even enters the operating room. Screw positioning and plate curvature are tailored pre-operatively to each vertebral level, which helps support consistent fixation and precise alignment for Anterior Cervical Discectomy and Fusion (ACDF) procedures.
When paired with the aprevo cervical planning and interbody fusion devices, the corra Personalized Plating System aims to provide anatomical fit and fixation customized to each patient's unique spine structure.
Analysts Remain Optimistic
Wall Street continues to show confidence in Carlsmed (CARL), with the stock carrying a Buy rating and an average price target of $20.25. Recent analyst activity includes:
- BTIG: Buy (Maintains Target to $24.00) (Dec. 15, 2025)
- Truist Securities: Buy (Raises Target to $20.00) (Nov. 7, 2025)
- BTIG: Buy (Raises Target to $24.00) (Nov. 7, 2025)
CARL Price Action: Carlsmed shares closed Wednesday up 5.99% at $11.85.
More News

Microsoft and Stellantis Are Building 100 AI Tools for Your Car. Here's What That Means.
Circle April 20th on your calendar

Schwab's Record Quarter Meets Crypto Rollout, But Stock Takes a Dive

PayPal's Rough Ride: Lawsuits, Scrapped Targets, and a Venmo Bright Spot

A Senator's Magnificent Seven Shopping Spree: Why He's Betting on Microsoft and Nvidia in 2026

Trump's Executive Order 14330: What Wall Street Doesn't Want You to Know

Navitas Semiconductor Stock Surges 13% After Adding Broadcom Veteran to Board

TotalEnergies Stock Jumps on Strong First-Quarter Forecast
Get Market News Alerts
Real-time alerts on price moves, news, and trading opportunities.
Join 20,000+ investors. No spam, ever.
Featured Articles
View all news
Microsoft and Stellantis Are Building 100 AI Tools for Your Car. Here's What That Means.

Trump's Executive Order 14330: What Wall Street Doesn't Want You to Know (Ad)

Schwab's Record Quarter Meets Crypto Rollout, But Stock Takes a Dive

PayPal's Rough Ride: Lawsuits, Scrapped Targets, and a Venmo Bright Spot

A Senator's Magnificent Seven Shopping Spree: Why He's Betting on Microsoft and Nvidia in 2026
Mar-a-Lago Bombshell (Ad)

Navitas Semiconductor Stock Surges 13% After Adding Broadcom Veteran to Board





